Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease

Abstract excerpt

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-previously described as nonalcoholic fatty liver disease-continues to rise globally. Despite this, therapeutic measures for MASLD remain limited. Recently, there has been a growing interest in the gut microbiome's role in the pathogenesis of MASLD. Understanding this relationship may allow for the administration of therapeutics...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gut microbiota and health
• Share to Liver Disease Diagnosis and Treatment
• Share to Pancreatitis Pathology and Treatment